Anne Grahl
InvestorAnalyst at Pureos Bioventures
Switzerland
Writes $100K – $5M checks · typically $1.5M
About
Anne Grahl is an Investment Manager at Pureos Bioventures with a background in biochemistry, structural biology, and biophysics. She works at the intersection of science and venture capital within the biotech sector.
Contact· self-published, not guessed
Experience
- Pureos BioventuresInvestment Managercurrent2025 — present
- Pureos BioventuresAssociate2023 — 2025Switzerland
- Pureos BioventuresAnalyst2021 — 2023Switzerland
- PulseSight TherapeuticsBoard Membercurrent2025 — present
- Mediar TherapeuticsBoard Observercurrent2023 — present
- YVC CollectiveBoard Membercurrent2023 — present
- M VenturesInvestment Analyst2021Amsterdam Area
- i&i PragueCollaborator2020 — 2021
- Biozentrum, University of BaselPostdoctoral Researcher2019 — 2021
- Biozentrum, University of BaselPhD Student2014 — 2018
Skills & more
Public SpeakingAnalytic Problem Solving1TeamworkInvestments1Project Leadership1Portfolio ManagementMembrane Proteins1BiophysicsBiochemistryScientific WritingTime Management1Molecular & Cellular Biology1
+5 more
ResearchProject ManagementComputational BiologyStructural BiologyCorporate Venture CapitalLanguages English · German
From Anne's professional profile.
Colleagues at Pureos Bioventures
Butrint Aliu
Analyst at Pureos Bioventures
Christian Altorfer
CFO/COO at Pureos Bioventures
Dominik Escher
Managing Partner at Pureos Bioventures
Dragan Grabulovski
Venture Partner at Pureos Bioventures
Klaus Breiner
Managing Partner at Pureos Bioventures
Lars Nieba
Venture Partner at Pureos Bioventures
Martin Münchbach
Managing Partner at Pureos Bioventures
Veronica Gambillara Fonck
Partner at Pureos Bioventures
Network5
Dominik Escher
Managing Partner at Pureos Bioventures
Dragan Grabulovski
Venture Partner at Pureos Bioventures
Klaus Breiner
Managing Partner at Pureos Bioventures
Lars Nieba
Venture Partner at Pureos Bioventures
Luigi Costa
Investor at Pureos Bioventures
Investors connected to Anne in public investor directories — a warm-intro map.
Frequently asked questions
- Who is Anne Grahl?
- Anne Grahl is an Investment Manager at Pureos Bioventures with a background in biochemistry, structural biology, and biophysics. She works at the intersection of science and venture capital within the biotech sector.
- Where does Anne Grahl work?
- Anne Grahl is Analyst at Pureos Bioventures.
- What check size does Anne Grahl write?
- Anne Grahl typically writes checks of $100K – $5M.
- Where did Anne Grahl go to school?
- Anne Grahl studied at Biozentrum, University of Basel (Doctor of Philosophy - PhD, Structural Biology); European Summer School (Entrepreneurship and New Venture Creation); Kiel University (Master of Science - MS, Biochemistry and Molecular Biology).
Same school
Also attended Biozentrum, University of Basel2
Also attended University of York77
Bob ThomasPartner at OxxNicole QuinnCo-Founder and Managing Partner at Connect VenturesPhil VenablesVenture Partner at Ballistic VenturesAnthony AvedissianPartner at Canonical CryptoConor ScanlanAssociate Partner at Nauta CapitalChris McCourtInvestment Director at Mercia Ventures
+ 71 more
Also attended Friedrich Schiller University Jena11
Yasmine ZiediJunior Analyst at GreenTec Capital PartnersAngela LawaldtManaging Partner at BONVENTUREMarkus DietrichSenior Investment Associate at Hadean VenturesHenri KühnertCo-Founder and Partner at b10Alena IvashenkaLife Sciences Investor at Venture Capital World SummitChristoph BrojaPartner at EQT Life Sciences
+ 5 more
Shared employers
Also worked at Pureos Bioventures11
Klaus BreinerManaging Partner at Pureos BioventuresDominik EscherManaging Partner at Pureos BioventuresMartin MünchbachManaging Partner at Pureos BioventuresButrint AliuAnalyst at Pureos BioventuresVeronica Gambillara FonckPartner at Pureos BioventuresAnja HarmeierHead Roche Venture Fund at Roche Venture Fund
+ 5 more
Also worked at PulseSight Therapeutics2
Also worked at Mediar Therapeutics8
Adam CottonPrincipal at Novartis Venture FundOliver WalkerManaging Partner at CGS Management AGChristoph KocherPrincipal at GimvAndreas JurgeitPartner at GimvRobert DrakasPresident at ShangPharma InnovationBharat SrinivasaPrincipal at Amplitude Venture Capital
+ 2 more





































_edited_edited.jpg)
